NCT06512610View on ClinicalTrials.gov

ELN 2022 in MENAFC ( Middle Eastern or North Coast of Africa ) Patients With Newly AML

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

August 1, 2024

Study Completion Date

January 1, 2025

Conditions
Leukemia, Myeloid
Interventions
OTHER

Middle Eastern or North Coast of Africa patients with newly AML

Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia in MENAFC patients

Trial Locations (1)

0600

CHU NICE, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT06512610 - ELN 2022 in MENAFC ( Middle Eastern or North Coast of Africa ) Patients With Newly AML | Biotech Hunter | Biotech Hunter